Incidentally Detected High-Grade Follicular Derived Non-Anaplastic Thyroid Carcinoma on 68Ga-PSMA PET-CT
PDF
Cite
Share
Request
Interesting Image
VOLUME: 34 ISSUE: 2
P: 159 - 161
June 2025

Incidentally Detected High-Grade Follicular Derived Non-Anaplastic Thyroid Carcinoma on 68Ga-PSMA PET-CT

Mol Imaging Radionucl Ther 2025;34(2):159-161
1. All India Institute of Medical Sciences, Clinic of Nuclear Medicine, Bhubaneswar, India
2. All India Institute of Medical Sciences, Clinic of Pathology, Bhubaneswar, India
No information available.
No information available
Received Date: 20.08.2024
Accepted Date: 08.01.2025
Online Date: 03.06.2025
Publish Date: 03.06.2025
E-Pub Date: 23.05.2025
PDF
Cite
Share
Request

Abstract

68Ga-prostate-specific membrane antigen (PSMA)-11 positron emission tomography/computed tomography (PET/CT) is currently routinely used for the evaluation of prostate cancer. However, due to its whole-body imaging capability, it can incidentally identify pathologies beyond prostate cancer. Herein, we describe a case of a 67-year-old man who was recently diagnosed with prostate carcinoma (PCa). The patient had a high PSMA-avid thyroid carcinoma detected incidentally during the initial staging of PCa with 68Ga-PSMA-11 PET-CT.

Keywords:
Thyroid carcinoma, incidental, prostate-specific membrane antigen, neovasculature

Ethics

Informed Consent: Informed consent was taken.

Authorship Contributions

Surgical and Medical Practices: P.S., S.M., A.K.A., G.K.P., K.A., Concept: P.S., S.M., A.K.A., Design: P.S., K.A., Data Collection or Processing: P.S., S.M., A.K.A., Analysis or Interpretation: P.S., S.M., A.K.A., K.A., Literature Search: P.S., S.M., Writing: P.S., S.M., A.K.A., G.K.P., K.A.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.

References

1
Hofman MS, Hicks RJ, Maurer T, Eiber M. Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls. Radiographics. 2018; 38:200-217.
2
de Galiza Barbosa F, Queiroz MA, Nunes RF, Costa LB, Zaniboni EC, Marin JFG, Cerri GG, Buchpiguel CA. Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging. 2020; 20:23.
3
Singh P, Kandula KK, Patel RK, Parida GK, Agrawal K. Incidental 68 Ga-PSMA uptake in the benign enchondroma-a rare finding on 68 Ga-PSMA PET/CT. Clin Nucl Med. 2024; 49:e525-e527.
4
Lauri C, Chiurchioni L, Russo VM, Zannini L, Signore A. PSMA expression in solid tumors beyond the prostate gland: ready for theranostic applications? J Clin Med. 2022; 11:6590.
5
Van de Wiele C, Sathekge M, de Spiegeleer B, De Jonghe PJ, Debruyne PR, Borms M, Beels L, Maes A. PSMA expression on neovasculature of solid tumors. Histol Histopathol. 2020; 35:919-927.